Prof. Gavin Churchyard receives A-rating from National Research Foundation
South Africa’s National Research Foundation has released its rating of researchers as part of its goal to develop an internationally competitive scientific research system. Aurum Group CEO Prof Gavin Churchyard
PanTB-HM Clinical Trial Begins Recruitment in South Africa
The panTB-HM clinical trial has begun patient recruitment in South Africa, with first patient dosed on 28 July 2023. This trial is a historic milestone in the quest to revolutionise
Lancet Commission Calls for Renewed Global Response on TB
As the United Nations High-Level Meeting (UNHLM) on TB approaches, a new report from the Lancet Commission on tuberculosis releases recommendations, providing a path forward to turn the tide on
Aurum Institute Ghana Receives Grand Challenges Grant For Catalyzing Equitable Artificial Intelligence (AI) Use
Aurum Institute Ghana announced this week that it is a winner of a Grand Challenges grant – an initiative fostering innovation to solve pressing global health and development problems and
Failure to implement contact tracing and tuberculosis prevention would result in close to 1 million deaths by 2035, according to new study
Combination intervention found to be cost-effective in averting illness and deaths in high-risk groups
People living in close contact with a person with TB disease are at highest risk of
250,000 patients to benefit from free access to short-course TB prevention treatment across seven countries
Johannesburg, 24 March 2023 – The Unitaid-funded IMPAACT4TB Consortium, led by the Aurum Institute, announced today that it will provide 250,000 patient courses of short course rifapentine-based preventive treatment regimens
